Inactive Instrument

News Chembio Diagnostics, Inc.

Equities

CEMI

US1635722093

Pharmaceuticals

Chembio Diagnostics, Inc. acquired FastPack® diagnostics business from Qualigen Therapeutics, Inc. for $5.8 million.	23-07-23	CI
CHEMBIO DIAGNOSTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-27	AQ
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.	23-04-27	AQ
Chembio Diagnostics, Inc.(NasdaqCM:CEMI) dropped from NASDAQ Composite Index	23-04-27	CI
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.	23-04-26	CI
Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex	23-04-20	PR
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023	23-04-19	AQ
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex	23-04-13	MT
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	23-04-13	AQ
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023	23-04-10	AQ
CHEMBIO DIAGNOSTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-04-06	AQ
Chembio’s CEO Letter to Stockholders	23-04-03	AQ
CHEMBIO DIAGNOSTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-29	AQ
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Biosynex: takeover bid extended for Chembio Diagnostics	23-03-29
Biosynex Unit Extends Expiration Time of Tender Offer for Chembio Diagnostics Shares; Stock Rises	23-03-29	MT
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	23-03-29	AQ
Chembio Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt	23-03-28	CI
CHEMBIO DIAGNOSTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-21	AQ
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023	23-03-21	AQ
CHEMBIO DIAGNOSTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-15	AQ
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	23-03-15	AQ
Chembio Announces Letter to Stockholders Regarding Tender Offer	23-03-15	AQ
Chembio Diagnostics, Inc.(NasdaqCM:CEMI) dropped from S&P TMI Index	23-03-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chembio Diagnostics, Inc.

Equities

CEMI

US1635722093

Pharmaceuticals

Filters